Roberto is an experienced technology business leader and operator. He is currently deployed as CEO of Brandprotect, where he engineered the turn-around of the core business from declining revenues to 75% year-over-year growth. He also serves as the CEO of Nulogx, a leading canadian transportation management solutions company and publisher of the Canadian General Freight Index.
Prior to joining Brandimensions, Roberto founded DME Consulting Inc., a management consulting firm specializing in strategy and M&A. Clients include Corel Corporation, AOL Canada, and BCE, where DME advised on several acquisitions with aggregate revenues north of $200 million.
Prior to DME Consulting, Roberto served as CEO for SoftQuad Software Ltd., a company he acquired through a management buy-out and subsequently took public both in the U.S. and Canada. Previously, Roberto was president of Carolian Systems, a network management software solutions company.
Elias is the Chairman and founder of Greybrook a private equity firm focused on Real Estate and Healthcare.
Elias is also Chairman of Greenbrook TMS NeuroHealth Centers (TSX: GTMS), the leading provider of TMS Therapy in North America. Greenbrook clinics provide a novel treatment for patients suffering with depression. He is also chairman of TearLab Corporation (NASDAQ/TEAR, TSX TLB), an ophthalmic device company developing and commercializing novel, lab-on-a-chip technologies that enable eye care practitioners to test for highly sensitive and specific biomarkers in tears at the point-of-care.
Prior to Greybrook, Elias co-founded TLCVision (NASDAQ/TLCV, TSX/TLC) where he served as President and CEO.
Elias, as CEO, built TLC into the largest eye care service provider organization in North America with revenues of more than $300,000,000 as TLC opened or acquired more than 100 laser eye clinics, over 200 mobile laser sites, more than 250 mobile cataract locations several ambulatory surgery centers and through its subsidiary Vision Source Inc. developed the largest independent Optometric Franchise with more than 2,000 locations.
TLC’s stock, listed on the TSX and NASDAQ since 1996, appreciated to well over $1 Billion during his tenure.
Elias has received many management awards from industry and his peers including.
As the CEO of Greybrook Securities Inc. and along with his partners, Sasha is responsible for leading the firm's capital markets and real estate investment strategies. Under his leadership and on behalf of it’s L.P.’s in over 30 countries, Greybrook’s portfolio has grown to include over 85 multi-family and residential development projects and nearly $20 billion worth of estimated completion value. Sasha co-chair’s Greybrook’s Investment and Project Advisory Committees that are responsible for approving new acquisitions and actively managing all existing project partnerships.
As the former President of Greybrook Health, Sasha also played a key role in several portfolio acquisitions including MacuHealth, Bruder Healthcare and TearLab, as well as the launch of Greenbrook TMS (NASDAQ: GBNH; TSX: GTMS), a leading provider of TMS therapy, an FDA-cleared, non-invasive therapy for the treatment of major depressive disorder. In 2020, he led the launch of Delos Canada, as well as Greybrook’s investment in Delos Living, LLC a global leader in the health and building sciences
Sasha’s directorships include representation on the board’s of Greenbrook, Neupath Health Inc. (TSX: NPTH), Greyspring Apartments and Delos Canada.
Charitably, Sasha serves on the boards of the Greybrook Foundation and the Blu Genes Foundation.
Peter is a partner at Greybrook and CEO of Greybrook Realty Partners. A private equity professional with over a decade of experience structuring, financing and managing investments, he oversees the strategic growth of Greybrook Realty Partners, a leading Toronto-based real estate private equity firm.
He leads the firm’s deal origination and asset management practice and is the co-chair of Greybrook Realty’s Investment Committee, responsible for providing oversight and approval of the company’s investments. Greybrook has invested in over 85 developments in the Greater Golden Horseshoe region and South Florida markets that represent in aggregate 43 million square feet of residential and commercial density with an estimated gross completion value of over $19 billion.
Peter also plays a critical role in the success of Greybrook Capital’s portfolio companies, serving on the boards of a number of Greybrook affiliated companies. He also serves on the board of Blu Genes Foundation, a charity funding the advancement of gene therapy sciences for the treatment of various genetic disorders.
Peter was recognized in 2018 as one of Canada’s Top 40 Under 40®, a coveted award for young business leaders celebrating the exceptional achievements of 40 outstanding Canadian leaders and innovators under the age of 40.